Human Papilloma Virus (HPV) Completed Phase 4 Trials for Human papillomavirus type 16 L1 capsid protein antigen (DB10301)

Back to Human Papilloma Virus (HPV)

Also known as: Human Papilloma Virus / HPV Infections / HPV (Human Papillomavirus) / Human Papillomavirus (HPV) / HPV Infection / Human Papillomavirus / HPV Disease / Papilloma Virus, Human / Human Papillomavirus Infection / Human papillomavirus infection (disorder) / Human papilloma virus infection / Human Papillomavirus Viruses / Human papillomavirus (organism) / Papillomavirus Infections / Disease caused by Papillomavirus (disorder) / Papilloma viral infection / Papilloma viral infection NOS / Papilloma viral infections

IndicationStatusPhase
DBCOND0040889 (Human Papilloma Virus (HPV))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00956553
Reactogenicity Study of Cervarix and Gardasil in UK Adolescent GirlsPrevention
NCT04590521
HPV Vaccine Immunity in High-risk WomenPrevention
NCT05435209
Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive AdolescentsPrevention
NCT01386164
Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected AdultsPrevention